Persistent Multisystem Physical Symptoms With Gastrointestinal Manifestations: A Self-Reported Case of Improvement Temporally Associated With Fluoxetine Use

Abstract Background: Persistent physical symptoms involving multiple systems can be difficult to characterise, particularly when investigations do not identify a single explanatory condition. A functional or psychiatric diagnosis should not be inferred solely from unrevealing investigations. Case presentation: A 28-year-old man, who was a medical student during the period described, reported approximately two years of dizziness, blurred vision, fatigue during prolonged sitting, epigastric discomfort, abdominal gas and distressing nocturnal abdominal distension. Symptoms affected concentration and academic functioning and were reported to worsen during periods of academic pressure. Examination was described as unremarkable apart from mild yellowish discoloration confined to the palms. Available laboratory results included haemoglobin 13.0 g/dL, mean corpuscular volume 60 fL, red blood cell count 6.7 × 10⁶/µL, white blood cell count 5,000/µL and ferritin 90 ng/mL. Stool microscopy reportedly identified amoebic cysts, the clinical significance of which was uncertain. Previous empirical treatments, including pantoprazole, antispasmodics, iron supplementation and repeated metronidazole courses, were not associated with sustained benefit. The patient independently formulated a possible somatic symptom disorder explanation; this was not established by an independent psychiatric assessment. He self-initiated paroxetine 20 mg daily for six months, reporting partial improvement and sexual adverse effects (delayed ejaculation and decreased libido). He then switched directly to fluoxetine 20 mg daily without documented medical supervision. Dizziness and blurred vision reportedly resolved within approximately eight weeks, with subsequent improvement in gastrointestinal symptoms. He reported sustained improvement during the first 18 months of daily fluoxetine use; thereafter, he used fluoxetine intermittently. Conclusion: This report documents a patient's retrospective account of improvement temporally associated with fluoxetine use. It cannot establish a psychiatric diagnosis, treatment efficacy or causation. Marked microcytosis without anaemia and the stool microscopy finding require separate interpretation and, where clinically appropriate, further evaluation.

Authors

Publication Details

Published
2026-11-13
DOI
https://doi.org/10.66977/xsci.2611.0023
Primary Topic
Psychosomatic Disorders and Their Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Persistent Multisystem Physical Symptoms With Gastrointestinal Manifestations: A Self-Reported Case of Improvement Temporally Associated With Fluoxetine Use

Galal Mohammed Ayad Qaid AlKarabi
2 links
Psychosomatic Disorders and Their Treatments
preprint

Persistent Multisystem Physical Symptoms With Gastrointestinal Manifestations: A Self-Reported Case of Improvement Temporally Associated With Fluoxetine Use

Galal Mohammed Ayad Qaid AlKarabi
preprint en

Abstract

Abstract Background: Persistent physical symptoms involving multiple systems can be difficult to characterise, particularly when investigations do not identify a single explanatory condition. A functional or psychiatric diagnosis should not be inferred solely from unrevealing investigations. Case presentation: A 28-year-old man, who was a medical student during the period described, reported approximately two years of dizziness, blurred vision, fatigue during prolonged sitting, epigastric discomfort, abdominal gas and distressing nocturnal abdominal distension. Symptoms affected concentration and academic functioning and were reported to worsen during periods of academic pressure. Examination was described as unremarkable apart from mild yellowish discoloration confined to the palms. Available laboratory results included haemoglobin 13.0 g/dL, mean corpuscular volume 60 fL, red blood cell count 6.7 × 10⁶/µL, white blood cell count 5,000/µL and ferritin 90 ng/mL. Stool microscopy reportedly identified amoebic cysts, the clinical significance of which was uncertain. Previous empirical treatments, including pantoprazole, antispasmodics, iron supplementation and repeated metronidazole courses, were not associated with sustained benefit. The patient independently formulated a possible somatic symptom disorder explanation; this was not established by an independent psychiatric assessment. He self-initiated paroxetine 20 mg daily for six months, reporting partial improvement and sexual adverse effects (delayed ejaculation and decreased libido). He then switched directly to fluoxetine 20 mg daily without documented medical supervision. Dizziness and blurred vision reportedly resolved within approximately eight weeks, with subsequent improvement in gastrointestinal symptoms. He reported sustained improvement during the first 18 months of daily fluoxetine use; thereafter, he used fluoxetine intermittently. Conclusion: This report documents a patient's retrospective account of improvement temporally associated with fluoxetine use. It cannot establish a psychiatric diagnosis, treatment efficacy or causation. Marked microcytosis without anaemia and the stool microscopy finding require separate interpretation and, where clinically appropriate, further evaluation.

Good health and well-being
Psychosomatic Disorders and Their Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon